Related Experiment Video

Updated: May 31, 2026

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
09:32

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge

Published on: January 20, 2023

Efficacy and cardiovascular tolerability of continuous veno-venous hemodiafiltration in acute decompensated heart

Sahar S I Badawy1, Ahmed Fahmy

  • 1Department of Anesthesia and Intensive Care, Cairo University, Egypt. saharbadawyi@yahoo.com

Journal of Critical Care
|July 9, 2011
PubMed

Insights

Continuous veno-venous hemodiafiltration (CVVHDF) offers superior fluid and weight loss for congestive heart failure (CHF) patients compared to furosemide. This treatment also reduces intensive care unit (ICU) length of stay safely.

Area of Science:

  • Cardiology
  • Nephrology
  • Critical Care Medicine

Background:

  • Congestive heart failure (CHF) management often involves fluid overload.
  • Continuous veno-venous hemodiafiltration (CVVHDF) is an emerging treatment option for CHF.
  • Intravenous furosemide is a standard therapy for fluid management in CHF.

Purpose of the Study:

  • To compare the efficacy and safety of CVVHDF versus intravenous furosemide in CHF patients.
  • To evaluate key outcomes including fluid balance, mortality, and ICU length of stay.

Main Methods:

  • Prospective, randomized, comparative trial involving 40 CHF patients.
  • Patients were randomized to 72-hour treatment with either CVVHDF or intravenous furosemide.
  • Outcomes included weight loss, fluid output, ICU length of stay (LOS), 30-day mortality, and cardiovascular stability.

Main Results:

  • CVVHDF group showed significantly greater weight loss and total fluid output (P ≤ .05 and P ≤ .01, respectively).
  • ICU LOS was significantly reduced in the CVVHDF group (P ≤ .05).
  • Both groups demonstrated improved cardiac output and stroke volume, with decreased pulmonary capillary wedge pressure; CVVHDF was associated with only one instance of transient hypotension.

Conclusions:

  • CVVHDF is an effective and safe treatment for fluid management in CHF.
  • CVVHDF achieved greater fluid and weight reduction compared to intravenous furosemide.
  • CVVHDF led to a shorter ICU length of stay without compromising hemodynamic stability.
Abstract

More Related Videos

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema08:44

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on: September 1, 2016

Related Concept Videos

Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...